154 related articles for article (PubMed ID: 8212321)
1. 5-HT and antidepressants: new views from microdialysis studies.
Artigas F
Trends Pharmacol Sci; 1993 Jul; 14(7):262. PubMed ID: 8212321
[No Abstract] [Full Text] [Related]
2. Clinical implication of microdialysis findings.
Deakin JF; Graeff FG; Guimaraes FS
Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
[No Abstract] [Full Text] [Related]
3. 5-HT and antidepressants: in vitro and in vivo release studies.
Briley M; Moret C
Trends Pharmacol Sci; 1993 Nov; 14(11):396-7. PubMed ID: 8296396
[No Abstract] [Full Text] [Related]
4. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.
Romero L; Hervás I; Artigas F
Neurosci Lett; 1996 Nov; 219(2):123-6. PubMed ID: 8971795
[TBL] [Abstract][Full Text] [Related]
7. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
[TBL] [Abstract][Full Text] [Related]
9. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
10. Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography.
Kovachich GB; Aronson CE; Brunswick DJ
Neuropsychopharmacology; 1992 Dec; 7(4):317-24. PubMed ID: 1476595
[TBL] [Abstract][Full Text] [Related]
11. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
Giambalvo CT; Price LH
Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
[TBL] [Abstract][Full Text] [Related]
13. Trazodone increases extracellular serotonin levels in the frontal cortex of rats.
Pazzagli M; Giovannini MG; Pepeu G
Eur J Pharmacol; 1999 Nov; 383(3):249-57. PubMed ID: 10594316
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
Auerbach SB; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
[TBL] [Abstract][Full Text] [Related]
15. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Hjorth S; Auerbach SB
Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
[TBL] [Abstract][Full Text] [Related]
17. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.
Guiard BP; Lanfumey L; Gardier AM
Curr Drug Targets; 2006 Feb; 7(2):187-201. PubMed ID: 16475960
[TBL] [Abstract][Full Text] [Related]
18. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action.
Scorza C; Silveira R; Nichols DE; Reyes-Parada M
Neuropharmacology; 1999 Jul; 38(7):1055-61. PubMed ID: 10428424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
